CRNX - Crinetics Pharmaceuticals, Inc.

QQQ $ 441.71 $ 1.04 (0.24 %)

DIA $ 395.04 $ 1.18 (0.3 %)

SPY $ 520.76 $ 0.67 (0.13 %)

TLT $ 90.14 $ -0.51 (-0.56 %)

GLD $ 218.73 $ 1.76 (0.81 %)

Previous Close

$ 48

Open

$ 49.92

Bid

$ 0.00 x 0

Ask

$ 48.75 x 100

Day's Range

$ 48.00 - $ 50.40

52 Week Range

$ 15.76 - $ 51.29

Volume

988,384

Average Volume

Market Cap

2.59B

Beta (5Y Monthly)

$ 0.88

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-09-2024	03-31-2024	10-Q
2	02-28-2024	12-31-2023	10-K
3	11-07-2023	09-30-2023	10-Q
4	08-08-2023	06-30-2023	10-Q
5	05-09-2023	03-31-2023	10-Q
6	02-28-2023	12-31-2022	10-K
7	11-14-2022	09-30-2022	10-Q
8	08-12-2022	06-30-2022	10-Q
9	05-12-2022	03-31-2022	10-Q
10	03-30-2022	12-31-2021	10-K
11	11-05-2021	09-30-2021	10-Q
12	08-10-2021	06-30-2021	10-Q
13	05-06-2021	03-31-2021	10-Q
14	03-30-2021	12-31-2020	10-K
15	11-06-2020	09-30-2020	10-Q
16	08-07-2020	06-30-2020	10-Q
17	05-08-2020	03-31-2020	10-Q
18	03-09-2020	12-31-2019	10-K
19	11-12-2019	09-30-2019	10-Q
20	08-13-2019	06-30-2019	10-Q
21	05-13-2019	03-31-2019	10-Q
22	03-13-2019	12-31-2018	10-K
23	11-13-2018	09-30-2018	10-Q
24	08-30-2018	06-30-2018	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

HC Wainwright & Co. Reiterates Buy on Crin...
05/10/2024 19:40:30

HC Wainwright & Co. analyst Douglas Tsao reiterates Crinetics Pharmaceuticals (NASDAQ:CRNX) with a Buy and maintains $60...

JMP Securities Reiterates Market Outperfor...
05/10/2024 16:45:04

JMP Securities analyst Jonathan Wolleben reiterates Crinetics Pharmaceuticals (NASDAQ:CRNX) with a Market Outperform and mai...

Crinetics Pharmaceuticals Q1 2024 GAAP EPS...
05/09/2024 20:40:40

Crinetics Pharmaceuticals (NASDAQ:CRNX) reported quarterly losses of $(0.93) per share which missed the analyst consensus estim...

Crinetics Pharmaceuticals To Present Advan...
05/08/2024 21:44:45

Initial Data from Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia to be Presented, Along with Initial Findings fr...

Piper Sandler Maintains Overweight on Crin...
05/07/2024 11:08:29

Piper Sandler analyst Yasmeen Rahimi maintains Crinetics Pharmaceuticals (NASDAQ:CRNX) with a Overweight and raises the pric...

Live On CNBC, StemPoint Capital CIO Michel...
04/03/2024 16:40:31

JMP Securities Reiterates Market Outperfor...
03/28/2024 14:41:23

JMP Securities analyst Jonathan Wolleben reiterates Crinetics Pharmaceuticals (NASDAQ:CRNX) with a Market Outperform and mai...

Oppenheimer Maintains Outperform on Crinet...
03/20/2024 15:52:20

Oppenheimer analyst Leland Gershell maintains Crinetics Pharmaceuticals (NASDAQ:CRNX) with a Outperform and raises the price...

JMP Securities Maintains Market Outperform...
03/20/2024 13:35:41

JMP Securities analyst Jonathan Wolleben maintains Crinetics Pharmaceuticals (NASDAQ:CRNX) with a Market Outperform and rais...

HC Wainwright & Co. Maintains Buy on Crine...
03/20/2024 10:35:16

HC Wainwright & Co. analyst Douglas Tsao maintains Crinetics Pharmaceuticals (NASDAQ:CRNX) with a Buy and raises the pri...

JonesTrading Maintains Buy on Crinetics Ph...
03/20/2024 10:08:30

JonesTrading analyst Lina Kaminski maintains Crinetics Pharmaceuticals (NASDAQ:CRNX) with a Buy and raises the price target ...

Crinetics Pharmaceuticals Inc Files For Re...
03/19/2024 20:43:13

- SEC Filing

endocrine-disease-focused-crinetics-pharmaceuticals-stock-soars-on-tuesday---heres-why

Endocrine Disease-Focused Crinetics Pharma...
03/19/2024 18:48:34

Crinetics Pharmaceuticals unveils PATHFNDR-2 Phase 3 results for paltusotine in acromegaly treatment. Statistically significant...

why-peraso-shares-are-trading-lower-by-over-23-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Why Peraso Shares Are Trading Lower By Ove...
03/19/2024 17:48:27

Shares of Peraso Inc. (NASDAQ: PRSO) fell sharply during Tuesday’s session after the company reported worse-than-expected four...

HC Wainwright & Co. Reiterates Buy on Crin...
03/19/2024 16:24:54

HC Wainwright & Co. analyst Douglas Tsao reiterates Crinetics Pharmaceuticals (NASDAQ:CRNX) with a Buy and maintains $50...

national-cinemedia-reports-upbeat-results-joins-nordstrom-core--main-and-other-big-stocks-moving-higher-on-tuesday

National CineMedia Reports Upbeat Results,...
03/19/2024 14:03:01

U.S. stocks were mixed, with the Dow Jones index gaining around 75 points on Tuesday.

Market-Moving News for March 19th
03/19/2024 12:41:16

CERS: 64% | Cerus Corporation Announces Its ReCePI Phase 3 Trial Of INTERCEPT Blood System Met Its Primary Efficacy Endpoint; S...

Crinetics Pharmaceuticals Announced Toplin...
03/19/2024 10:06:38

JMP Securities Reiterates Market Outperfor...
03/13/2024 15:25:25

JMP Securities analyst Jonathan Wolleben reiterates Crinetics Pharmaceuticals (NASDAQ:CRNX) with a Market Outperform and mai...

Oppenheimer Reiterates Outperform on Crine...
03/13/2024 12:34:22

Oppenheimer analyst Leland Gershell reiterates Crinetics Pharmaceuticals (NASDAQ:CRNX) with a Outperform and raises the pric...